Authors' Reply.

Batlle, Daniel; Soler, Maria Jose; Welling, Paul A; Swaminathan, Sundararaman

Authors' Reply.

Batlle, Daniel; Soler, Maria Jose; Welling, Paul A; Swaminathan, Sundararaman.

Batlle D; Nephrology Division, Feinberg School of Medicine, Northwestern University, Chicago, Illinois d-batlle@northwestern.edu.
Soler MJ; Nephrology Division, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain.
Welling PA; Nephrology Division, Johns Hopkins University, Baltimore, Maryland.
Swaminathan S; Nephrology Division, University of Virginia, Charlottesville, Virginia.

J Am Soc Nephrol ; 31(8): 1918-1919, 2020 08.

Article in English | MEDLINE | ID: covidwho-1383789

Subject(s)

Acute Kidney Injury; Betacoronavirus; Coronavirus Infections; Pandemics; Pneumonia, Viral; COVID-19; Humans; Renin-Angiotensin System; SARS-CoV-2

Keywords

ACE inhibitors; AKI; Angiotensin II receptor blockers; ace2; acute renal failure; covid-19; soluble ACE2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Acute Kidney Injury / Pandemics / Betacoronavirus Limits: Humans Language: English Journal: J Am Soc Nephrol Journal subject: Nephrology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google